Plaisance Capital Management
Overview
Established in 2020, Plaisance Capital Management is an investment management company focused on fostering the growth of entrepreneurs and ideas, investing in biotech startups and providing them with resources and guidance . The firm provides mentorship and helps companies navigate the challenges of scaling their businesses .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Stellaromics | Nov 2023 | Series A | Co-investor |
| HebeCell | Aug 2021 | Series A | - |
| Reunion Neuroscience Inc. | Sep 2025 | Series A Extension | Co-investor |
| Perceptive Technologies | Jan 2025 | Series B | Co-investor |
| ProteoValent Therapeutics | - | Seed | Lead |
For institutional investors. Book with your work email.
Key People
Diana West-Szymanski
Principal (Chicago Location) And Director Of Operations
Wendy Liu
Principal
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Plaisance Capital Management based?
Plaisance Capital Management is headquartered in Cambridge, Massachusetts, United States.
When was Plaisance Capital Management founded?
Plaisance Capital Management was founded in 2020.
How many portfolio companies does Plaisance Capital Management have?
Plaisance Capital Management has 13 portfolio companies in Caplight's dataset.
What are some companies in Plaisance Capital Management's portfolio?
Portfolio companies visible on Caplight include Stellaromics, HebeCell, Reunion Neuroscience Inc., Perceptive Technologies, ProteoValent Therapeutics.
What was Plaisance Capital Management's most recent investment shown here?
Plaisance Capital Management's most recent investment in this portfolio sample was in Reunion Neuroscience Inc. in 2025.
What sectors does Plaisance Capital Management focus on?
Plaisance Capital Management focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Healthcare & Life Sciences, Enterprise Software, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does Plaisance Capital Management focus on?
Plaisance Capital Management typically invests at the Early stage.
What is Plaisance Capital Management's AUM?
Plaisance Capital Management's assets under management are estimated between $100.0M and $250.0M.